Teva Pharmaceutical Industries reported $12.67B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 71.19B 5.78B Jun/2026
Dr.Reddys Laboratories INR 80.71B 5.25B Jun/2026
Guangzhou Baiy CNY 16.05B 7.23B Dec/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kalbe Farma IDR 9.34T 431B Mar/2026
Richter Gedeon HUF 220.2B 5.51B Mar/2026
Sh Fosun Pharma CNY 10.07B 260M Dec/2026
Sun Pharmaceuticals INR 153B 7.14B Jun/2026
Teva Pharmaceutical Industries USD 12.67B 900M Jun/2026